Evidence map›Paper›PMID 27354311›Full record

ReviewTrends in endocrinology and metabolism: TEM2016

Anticipatory UPR Activation: A Protective Pathway and Target in Cancer.

David J Shapiro, Mara Livezey, Liqun Yu, Xiaobin Zheng, Neal Andruska

Open access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David J ShapiroDepartment of Biochemistry, University of Illinois, Urbana, IL 61801, USA. Electronic address: djshapir@life.illinois.edu.
Mara LivezeyDepartment of Biochemistry, University of Illinois, Urbana, IL 61801, USA.
Liqun YuDepartment of Biochemistry, University of Illinois, Urbana, IL 61801, USA.
Xiaobin ZhengDepartment of Biochemistry, University of Illinois, Urbana, IL 61801, USA.
Neal AndruskaDepartment of Biochemistry, University of Illinois, Urbana, IL 61801, USA; College of Medicine, University of Illinois, Urbana, IL 61801, USA.
University of Illinois Urbana-Champaign · US

Funding

Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
Targeting Breast Cancer with Small Molecule Inhibitors of Estrogen ReceptorR01DK071909 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI SHAPIRO, DAVID J · 2005 to 2020
$4.3M
NIDDK NIH HHS R01 DK071909NIGMS NIH HHS T32 GM070421
6 · The paper itself

Abstract

The endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), plays a key role in regulating intracellular protein homeostasis. The extensively studied reactive mode of UPR activation is characterized by unfolded protein, or other EnR stress, triggering UPR activation. Here we focus on the emerging anticipatory mode of UPR activation in which mitogenic steroid and peptide hormones and other effectors preactivate the UPR and anticipate a future need for increased protein folding capacity. Mild UPR activation in breast cancer can be protective and contributes to antiestrogen resistance. Hyperactivation of the anticipatory UPR pathway in cancer cells with a small molecule converts it from cytoprotective to cytotoxic, highlighting its potential as a therapeutic target in estrogen receptor-positive breast cancer.

Indexed as

AnimalsEndoplasmic Reticulum StressGene Expression Regulation, NeoplasticHumansNeoplasmsSignal TransductionUnfolded Protein ResponseBHPIcancerestrogenunfolded protein response

Identifiers

PMID27354311
PMCPMC5035594
OpenAlexW2463714514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.